159 related articles for article (PubMed ID: 6698577)
41. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system.
Venneker GT; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; de Waall LP; Bos JD; Asghar SS
Exp Clin Immunogenet; 1996; 13(2):104-11. PubMed ID: 9063702
[TBL] [Abstract][Full Text] [Related]
42. Mouse C4 (Ss): three-step purification of its C4c fragment and production of a monospecific antiserum.
Ferreira A; Nussenzweig V
J Immunol; 1979 Feb; 122(2):490-3. PubMed ID: 762433
[TBL] [Abstract][Full Text] [Related]
43. Mouse C3b/C4b inactivator: purification and properties.
Kai S; Fujita T; Gigli I; Nussenzweig V
J Immunol; 1980 Dec; 125(6):2409-15. PubMed ID: 6776193
[TBL] [Abstract][Full Text] [Related]
44. The purification and properties of the second component of guinea-pig complement.
Kerr MA; Gagnon J
Biochem J; 1982 Jul; 205(1):59-67. PubMed ID: 6922702
[TBL] [Abstract][Full Text] [Related]
45. Substrate specificities of the protease of mouse serum Ra-reactive factor.
Ogata RT; Low PJ; Kawakami M
J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
[TBL] [Abstract][Full Text] [Related]
46. Partial characterization of procomplementary activity of porcine serum and its relationship to the fifth component of complement.
Jensen MT; Stone SS
Am J Vet Res; 1981 Dec; 42(12):2071-3. PubMed ID: 6176150
[TBL] [Abstract][Full Text] [Related]
47. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
Laham MN; Caldwell JR; Panush RS
J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
[TBL] [Abstract][Full Text] [Related]
48. Isolation and characterization of a novel plasma protein which binds to activated C4 of the classical complement pathway.
Hammer CH; Jacobs RM; Frank MM
J Biol Chem; 1989 Feb; 264(4):2283-91. PubMed ID: 2492518
[TBL] [Abstract][Full Text] [Related]
49. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
[TBL] [Abstract][Full Text] [Related]
50. Proteolysis of C2 and factor B: analyses of cleavage products by one- and two- dimensional peptide mapping.
Ngan BY; Minta JO
Mol Immunol; 1981 Dec; 18(12):1035-47. PubMed ID: 7038446
[No Abstract] [Full Text] [Related]
51. The complex of C5b and C6: isolation, characterization, and identification of a modified form of C5b consisting of three polypeptide chains.
Yamamoto KI; Gewurz G
J Immunol; 1978 Jun; 120(6):2008-15. PubMed ID: 659890
[No Abstract] [Full Text] [Related]
52. Monoclonal antibodies to human C4. I. Purification of hemolytically active C4 from small volumes of normal serum.
Spinella DG; Shah DD; Hale PD; Levine RP
Complement; 1984; 1(4):187-93. PubMed ID: 6399882
[TBL] [Abstract][Full Text] [Related]
53. Purification and structural analysis of the fourth component of human complement.
Bolotin C; Morris S; Tack B; Prahl J
Biochemistry; 1977 May; 16(9):2008-15. PubMed ID: 322709
[TBL] [Abstract][Full Text] [Related]
54. The second component (C2n) of the nurse shark complement system: purification, physico-chemical characterization and functional comparison with guinea pig C4.
Smith SH; Jensen JA
Dev Comp Immunol; 1986; 10(2):191-206. PubMed ID: 3743848
[TBL] [Abstract][Full Text] [Related]
55. Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity.
Wetsel RA; Kolb WP
J Immunol; 1982 May; 128(5):2209-16. PubMed ID: 7061860
[No Abstract] [Full Text] [Related]
56. Fourth component of human complement: description of a three polypeptide chain structure.
Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1974 Nov; 140(5):1324-35. PubMed ID: 4424566
[TBL] [Abstract][Full Text] [Related]
57. Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.
Kerr MA
Biochem J; 1979 Dec; 183(3):615-22. PubMed ID: 261515
[TBL] [Abstract][Full Text] [Related]
58. Purification of the fifth component of murine complement from ascites fluid.
Lin RH; Stockinger B
J Immunol Methods; 1988 Nov; 115(1):127-31. PubMed ID: 3192942
[TBL] [Abstract][Full Text] [Related]
59. Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay.
Wetsel RA; Jones MA; Kolb WP
J Immunol Methods; 1980; 35(3-4):319-35. PubMed ID: 6995534
[TBL] [Abstract][Full Text] [Related]
60. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
